Last reviewed · How we verify

NCT04770948: GUESS

An RCT of 19G EBUS-TBNA Needle in Suspected Sarcoidosis

Completed NA Last updated 29 November 2023
What this trial tests

NA trial testing 19 gauge needle in Sarcoidosis in 150 participants. Completed in 30 September 2023.

Timeline
1 March 2021
Primary endpoint
28 February 2023
30 September 2023

Quick facts

Lead sponsorPost Graduate Institute of Medical Education and Research, Chandigarh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment150
Start date1 March 2021
Primary completion28 February 2023
Estimated completion30 September 2023
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Who can join

18 and older, any sex, with Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sarcoidosis is an idiopathic disorder characterized by granulomatous inflammation involving various organ systems. The lung and mediastinal lymph nodes are the most commonly involved structures in sarcoidosis. In the presence of intrathoracic lymph nodes, transbronchial needle aspiration (TBNA) is a useful diagnostic modality, which is now guided using endobronchial ultrasound (EBUS). We hypothesize that the 19-gauge EBUS-TBNA needle will have a higher yield as compared to the conventional 22-gauge EBUS-TBNA needle in intrathoracic lymphadenopathy due to sarcoidosis. In this study, we plan to evaluate the yield and safety of the 19-gauge needle vs. the conventional 22-gauge EBUS-TBNA needle in patients with sarcoidosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcoidosis

Currently open trials in the same condition.

Other Post Graduate Institute of Medical Education and Research, Chandigarh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04770948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing